The Effect of Chemoradiotherapy with SRC Tyrosine Kinase Inhibitor, PP2 and Temozolomide on Malignant Glioma Cells <i>In Vitro</i> and <i>In Vivo</i>
Keun‐Yong Eom(Seoul National University), In Ah Kim(Seoul National University)
Cited by 31